Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy
Clinical trial NCT07310186 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07310186
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-12-30
- Primary completion
- 2026-12-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.